Incidence of osteonecrosis of the jaw by the use of osteoclast inhibitors in patients with bone metastases: a retrospective cohort study.

Chaurand-Lara, Jorge

Incidence of osteonecrosis of the jaw by the use of osteoclast inhibitors in patients with bone metastases: a retrospective cohort study. [electronic resource] - Cirugia y cirujanos 2019 - 396-401 p. digital

Publication Type: Journal Article

2444-054X

10.24875/CIRU.18000661 doi


Adult
Aged
Aged, 80 and over
Alendronate--adverse effects
Bisphosphonate-Associated Osteonecrosis of the Jaw--epidemiology
Bone Density Conservation Agents--adverse effects
Bone Neoplasms--drug therapy
Denosumab--adverse effects
Diphosphonates--adverse effects
Female
Humans
Incidence
Male
Mexico--epidemiology
Middle Aged
Osteoclasts--drug effects
Retrospective Studies
Risedronic Acid--adverse effects
Time Factors
Zoledronic Acid--adverse effects